Clinical trial
Pipeline Embolization Device for Intracranial Aneurysm (PEDIA): a Prospective, Multicenter Cohort Focus on Safety, Efficacy, and Haemodynamics
NCT06446778 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pipeline Embolization Device for Intracranial Aneurysm (PEDIA): a Prospective, Multicenter Cohort Focus on Safety, Efficacy, and Haemodynamics
- Lead sponsor
- Zhujiang Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- September 1, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aneurysm, intracranial, efficacy, self, hemodynamic instability, stenosis